The Effect of Olive Leaf Extract Administration on Cardiovascular Health
Not Applicable
Completed
- Conditions
- Elevated CholesterolOverweight and Obesity
- Interventions
- Dietary Supplement: OLECOLDietary Supplement: Placebo
- Registration Number
- NCT02990637
- Lead Sponsor
- Maastricht University Medical Center
- Brief Summary
The purpose of this study is to investigate the effects of daily supplementation of OLECOL for a period of 8 weeks on cardiovascular risk markers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
- Healthy individuals
- Age between 18 and 70 years
- Total cholesterol levels ≥ 5.0 mmol/L
- BMI 25-35 kg/m2
Exclusion Criteria
- History of severe cardiovascular, respiratory, urogenital, gastrointestinal/hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat). Dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological diseases, allergy, major surgery and /or laboratory assessments that might limit participation in or completion of the study protocol.
- Diabetes
- Use of medication that might have influence on endpoints (e.g. cholesterol lowering medication, hypertension medication)
- Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study in the 180 days prior to the study
- Use of antibiotics in the 30 days prior to the start of the study
- Use of antioxidants, minerals and vitamin supplements available in pharmacies, drugstores, food markets or in alternative medicine
- Pregnancy, lactation
- Abuse of products (> 20 alcoholic consumptions per week and drugs)
- Smoking
- Weight gain or loss (> 3 kg in previous 3 months)
- High physical activity (>4.5 hours of running/week)
- History of any side effects towards intake of olives
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description OLECOL OLECOL Olive leaf extract Placebo Placebo Maltodextrin
- Primary Outcome Measures
Name Time Method Blood lipid profile 8 weeks
- Secondary Outcome Measures
Name Time Method Glucose metabolism 8 weeks Systolic and diastolic blood pressure 8 weeks Lipid peroxidation 8 weeks
Trial Locations
- Locations (1)
Maastricht University Medical Center
🇳🇱Maastricht, Netherlands